ERBB2 and neoplasm: Trogocytic interactions have been characterized in tumor cells as early as 2015 but have largely been mostly focused on the transfer of proteins from tumor cells to immune cells, such as PD-1/PD-L1and HER2 transfer (Hasim et al., 2022; Suzuki et al., 2015).